Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 15 Aug 23 EFFECT Notice of effectiveness
-
10 Aug 23 S-1/A IPO registration (amended)
- 3 Aug 23 S-1/A IPO registration (amended)
- 7 Jul 23 S-1 IPO registration
EVFM similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement No. 333-273185 on Form S-1 of our report dated April 27, 2023 (July 7, 2023, as to the effects of the reverse stock split described in Note 14), relating to the financial statements of Evofem Biosciences, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ DELOITTE & TOUCHE LLP
San Diego, California
August 10, 2023